Table 3.
Knowledge regarding antibiotic therapy for infections according to the study factors
| Upper respiratory infection Me (IQR) |
Pneumonia Me (IQR) |
UTI Me (IQR) |
Skin and soft tissue infection Me (IQR) |
||
|---|---|---|---|---|---|
| Academic term | Basic | 46.4 (35.7–50.0) | 50.0 (41.7–58.3) | 57.1 (42.9–66.7) | 55.6 (44.4–77.8) |
| Clinical areas | 42.9 (35.7–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–71.4) | 66.7 (44.4–77.8) | |
| Internship | 46.4 (39.3–53.6) | 50.0 (50.0–66.7) | 61.9 (52.4–71.4) | 66.7 (55.6–77.8) | |
| P value | 0.549 | 0.051 | 0.001** | 0.002** | |
| University | U1 | 42.9 (35.7–50.0) | 50.0 (41.7–58.3) | 57.1 (42.9–66.7) | 55.6 (44.4–77.8) |
| U2 | 42.9 (35.7–50.0) | 50.0 (50.0–66.7) | 61.9 (52.4–66.7) | 66.7 (55.6–77.8) | |
| U3 | 46.4 (39.3–53.6) | 50.0 (50.0–66.7) | 61.9 (52.4–71.4) | 66.7 (44.4–77.8) | |
| P value | 0.115 | 0.100 | 0.000** | 0.002** | |
| Knowing when to initiate antibiotic treatment | No | 46.4 (39.3–50.0) | 58.3 (50.0–66.7) | 61.9 (52.4–71.4) | 55.6 (44.4–77.8) |
| Yes | 42.9 (35.7–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–66.7) | 66.7 (55.6–77.8) | |
| P value | 0.535 | 0.323 | 0.481 | 0.109 | |
| Selecting the antibiotics for each infection | No | 46.4 (39.3–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–71.4) | 55.6 (44.4–77.8) |
| Yes– | 42.9 (35.7–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–66.7) | 66.7 (55.6–77.8) | |
| P value | 0.574 | 0.456 | 0.693 | 0.234 | |
| Understanding the basic resistance mechanisms | No | 46.4 (39.4–53.6) | 58.3 (50.0–66.7) | 61.9 (57.1–71.4) | 55.6 (44.4–77.8) |
| Yes | 42.9 (35.7–50.0) | 50.0 (41.7–66.7) | 57.1 (47.6–66.7) | 66.7 (55.6–77.8) | |
| P value | 0.107 | 0.028* | 0.041* | 0.804 | |
| Interpreting antibiograms | No | 46.4 (39.3–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–71.4) | 66.7 (55.6–77.8) |
| Yes | 42.9 (35.7–53.6) | 50.0 (41.7–58.3) | 57.1 (47.6–66.7) | 55.6 (44.4–77.8) | |
| P value | 0.909 | 0.107 | 0.055 | 0.002** | |
| Finding reliable sources of information | No | 46.4 (39.3–50.0) | 50.0 (41.7–66.7) | 61.9 (52.4–66.7) | 55.6 (44.4–77.8) |
| Yes | 42.9 (39.3–50.0) | 50.0 (41.7–66.7) | 61.9 (47.6–66.7) | 66.7 (44.4–77.8) | |
| P value | 0.384 | 0.515 | 0.393 | 0.691 | |
| Switching from IV to oral antibiotics | No | 42.9 (39.3–50.0) | 50.0 (50.0–66.7) | 61.9 (52.4–71.4) | 66.7 (44.4–77.8) |
| Yes | 42.9 (35.7–50.0) | 50.0 (41.7–58.3) | 57.1 (47.6–66.7) | 55.6 (44.4–77.8) | |
| P value | 0.329 | 0.131 | 0.002** | 0.664 | |
| Research or education | No | 46.4 (39.3–53.6) | 50.0 (41.7–66.7) | 61.9 (52.4–66.7) | 66.7 (55.6–77.8) |
| Yes | 42.9 (35.7–50.0) | 50.0 (41.7–66.7) | 57.1 (47.6–66.7) | 66.7 (44.4–77.8) | |
| P value | 0.400 | 0.697 | 0.259 | 0.869 |
Basic: Includes students from the first to fifth semesters
Clinical areas: Includes students from the sixth to tenth semesters
Internship: Includes students from the eleventh and twelfth semesters
For confidentiality, the three universities included were coded as U1, U2, and U3.
IV Intravenous
UTI Urinary tract infection
Me Median
IQR Interquartile range
* P value < 0.05, ** P value < 0.01